Rules of thumb don't account for how institutional buyers actually price a business. A proper valuation study does. It combines financial analysis, market data, and industry benchmarking to determine what your company is truly worth to the buyers most likely to acquire it.
But the number is not the deliverable. A study earns its fee by telling you why the number is what it is, in order of severity. Its real output is a ranked list of what is holding your multiple down, produced while you can still fix it.
This guide covers the core methods, what drives premium pricing, and how to read a study as a diagnostic rather than a verdict.
Key Takeaways
- Valuation studies combine multiple methodologies, not a single formula or online calculator
- Middle-market companies ($10M-$100M revenue) require different analysis than public companies or small local businesses
- Precedent transaction research and buyer universe mapping are often overlooked, and critical to a defensible value range
- A low indicated multiple is not an insult. It prices the work a buyer thinks it will have to do
- Professional valuation research surfaces value gaps before you go to market, not after
What Is a Business Valuation Study?
A valuation study is the structured process of estimating a company's economic value using financial statements, market data, and industry-specific factors. It follows formal standards from the American Society of Appraisers and the AICPA, producing a defensible estimate rather than a multiple pulled from a trade publication. Two assessments are easy to confuse:
- Formal valuation: used for M&A transactions, litigation, or estate planning, following recognized standards and ending with a defensible conclusion of value
- Broker opinion of value (BOV): a more limited, informal assessment, often used as a starting point rather than a final answer The AICPA's standards for valuation services even distinguish between a full "valuation engagement" (where the analyst selects methods and reaches a conclusion of value) and a narrower "calculation engagement" that may produce a different number entirely. Confirm which engagement type you are buying before you rely on the number.
Why Middle-Market Companies Need Different Analysis
Public company models assume liquid stock, diversified ownership, and analyst coverage. None of that applies to a company with $2M-$10M in EBITDA run by a single founder. These businesses need adjustments for owner dependency, thinner management benches, and less predictable revenue. Your objective also shapes the approach. A valuation for a sale looks different than one for recapitalization or succession planning: each weighs different factors and serves a different audience. At Exit Boston, Co-Founder Steve Vesey brings 25+ years of CPA-led valuation work to this process, grounding every engagement in defensible financial analysis rather than shortcuts.
Core Valuation Methodologies Used in Research
Credible valuation research doesn't rely on one method. It cross-checks multiple approaches to arrive at a defensible range.
Income-Based Approaches
Discounted cash flow (DCF) analysis converts a company's anticipated future cash flows into a present-day value. It requires defensible assumptions about growth rate and discount rate (weighted average cost of capital). Those assumptions can swing the output dramatically if they're not grounded in reality.
Capitalization of earnings works better for businesses with stable, predictable cash flows. Instead of projecting years of future performance, it divides a representative earnings figure by a capitalization rate.
Market-Based Approaches
EBITDA multiples anchor valuation to comparable industry transactions. According to GF Data's 2025 benchmarks, which track PE-sponsored deals in the $10M-$500M range:
- Manufacturing companies in the $25M–$50M TEV band averaged a 5.3x EBITDA multiple
- Distribution companies in that same band averaged 7.4x
- Manufacturing multiples in the $50M–$100M band climbed to 8.6x
Precedent transaction analysis goes further, examining completed deals in your sector. Access to current proprietary deal data, rather than stale rules of thumb, directly affects its accuracy.
Asset-Based Approaches
Book value and liquidation value serve as a floor-value reference, particularly for asset-heavy industries like manufacturing and distribution. This method rarely represents the ceiling for a healthy operating business, but it establishes the minimum worth of the underlying assets.
Most credible studies use at least two of these methods to cross-validate the range. If yours leans on a single number from a single method, treat it with skepticism.
What Drives Valuation in Middle-Market Research
Multiples aren't handed out evenly. Buyers price in risk, and certain characteristics move that perceived risk. Key drivers include:
- Recurring revenue: predictable, contracted income reduces buyer risk and supports higher multiples
- Customer concentration: heavy reliance on a few accounts signals fragility and typically compresses multiples
- Management depth: a business that runs without the founder is worth more than one that doesn't
- Financial clarity: clean, well-documented financials supported by KPIs a buyer can underwrite
Recast EBITDA quality is critical. Pepperdine's 2025 Private Capital Markets Report found recast EBITDA multiples carried the highest average weighting among valuation factors, at 38%. If your add-backs aren't defensible, your valuation isn't either.
Sector context matters too. Capstone Partners data shows clear gaps by industry:
- Building products: 10.6x EV/EBITDA (2025–early 2026) vs. 9.4x in 2024
- Broader middle market: 9.8x in 2025
- Chemicals: 10.0x, ahead of broader industrials at 9.0x
Those spreads are exactly why generic multiples don't work.
Intangibles also shape the premium. Brand equity, proprietary processes, and durable customer relationships are harder to quantify than a line item, but buyers weigh them heavily.
Reading the Study: A Ranked List, Not a Verdict
A study that returns only a range has told you nothing you can act on. One worth commissioning tells you which characteristics are compressing the multiple, and in what order.
Consider a New Hampshire precision aerospace machining business with roughly $8.5 million of EBITDA and a customer list of aerospace OEMs. Early indications of value clustered at roughly 6x. The founder's instinct was that the market had misjudged the company. The diagnostic said otherwise, and it was specific. Buyers had flagged four things:
- Critical decisions concentrated with the founder. A continuity problem, not a capability problem.
- Limited management depth beneath ownership. No tested layer to run the business through a transition.
- Financial reporting structured for internal management rather than institutional review. Accurate for running the company, not for underwriting it.
- Incentive systems loosely aligned with long-term growth. Nothing tying the people who deliver the plan to the plan.
Read that way, the low multiple stops being an argument and becomes information. As Exit Boston's own material puts it, the initial indications at 6x were not an insult, they were a signal. When investors apply a lower multiple they are not punishing the seller; they are pricing in the work they believe they will have to do.
The founder paused rather than accepting, and worked the list. What the investment committee saw the second time was the same list inverted: tested management roles, reporting built for institutional review, contracts giving forward revenue visibility, and a founder willing to roll equity.
That is what a study is for. The range is the summary. The list is the product.
Why Professional Valuation Research Matters Before Going to Market
A self-prepared valuation, or one a few years old, almost always underestimates market value. Founders don't have visibility into current precedent transactions or which buyers are actively acquiring in their space.
Buyer universe identification changes the equation. Mapping the landscape and identifying qualified acquirers creates the competitive tension that drives premium offers:
- Private equity firms
- Strategic acquirers
- Family offices
A single interested buyer has no incentive to stretch on price. Five interested buyers do.
Preparation shows up in the numbers. GF Data's analysis of 360 transactions completed since Q3 2024 found sellers who used sell-side quality-of-earnings reports averaged 7.4x TEV/EBITDA, compared to 7.0x for sellers who didn't. The benefit was most pronounced above $50M in deal size.
At Exit Boston this research function sits with Laura, Senior Research Analyst, who delivers precedent transaction research and target buyer profiling so valuation strategy rests on current market intelligence, not multiples from three years ago.
Common Valuation Research Mistakes Founders Make
Founders don't undervalue their companies on purpose. They make avoidable errors:
- Relying on outdated rules of thumb. A multiple heard secondhand two years ago doesn't reflect current precedent transactions or market conditions.
- Overlooking normalized EBITDA adjustments. Skipping add-backs for one-time expenses or non-market owner compensation understates true earnings power when those adjustments are documented and defensible.
- Ignoring intangible value drivers. Recurring revenue and strong customer relationships often go unquantified, so founders price below what buyers will pay.
The common thread: these mistakes surface after a buyer's diligence team finds them, not before. By then it's a negotiating disadvantage rather than a ranked to-do list.
When and How to Commission a Valuation Study
Timing matters as much as methodology. RSM's 2025 exit-readiness research recommends starting pre-planning one to two years before a planned exit, with active marketing beginning three to six months out.
That window exists for a reason: it gives you time to fix what the study uncovers. A typical middle-market M&A advisory engagement includes:
- Financial analysis: normalized EBITDA, historical performance, and defensible add-backs
- Industry benchmarking: current precedent transactions and sector-specific multiples
- Buyer readiness assessment: identifying value gaps before a buyer's diligence team does, ranked by how much multiple each one is costing you
- Investment Summary preparation: positioning the opportunity for qualified, motivated buyers
Exit Boston works with founders generating $10M-$100M in revenue and $2M-$10M in EBITDA, turning valuation findings into an actionable exit strategy instead of a report that never gets used.
Frequently Asked Questions
What is the difference between a business valuation and a business appraisal?
The terms are often used interchangeably in M&A contexts. "Appraisal" is more common in real estate or asset-specific contexts, while "valuation" typically refers to enterprise or equity value analysis for a full business.
How much does a professional business valuation cost?
Cost varies significantly by complexity, purpose, and scope of the engagement. Many M&A advisory firms include valuation work as part of a broader exit-planning engagement rather than pricing it as a standalone service.
What financial documents are needed for a valuation study?
Expect to provide 3-5 years of financial statements, corporate tax returns, and forward-looking projections. Buyers also review compliance documentation and quality-of-earnings materials during diligence.
How often should a business owner update their valuation?
Annually or every two years is a reasonable baseline, but update more frequently as you approach a planned exit. Market multiples and buyer appetite shift, and a stale valuation can misguide your decisions.
Can a valuation study help increase my company's sale price?
Yes, but only if you treat it as a diagnostic. Its ranked list of gaps (founder dependency, reporting built for internal use, misaligned incentives) is what you act on, months before a buyer's team finds them.
What's the difference between valuing a business for sale versus for internal planning?
Sale-focused valuations emphasize the buyer's perspective and current market comparables. Internal valuations, used for succession or tax planning, may weight different factors like tax basis or family transfer considerations.
